Publications: Dr Jessica Okosun
Dreyling M, André M, Gökbuget N, Tilly H, Jerkeman M, Gribben J, Ferreri A, Morel P et al.
(
2022
)
.
The EHA Research Roadmap: Malignant Lymphoid Diseases
.
HemaSphere
vol.
6
,
(
6
)
Wu F, Watanabe N, Tzioni MM, Akarca A, Zhang C, Li Y, Chen Z, Cucco F et al.
(
2021
)
.
Thyroid MALT lymphoma: self-harm to gain potential T-cell help
.
Leukemia
vol.
35
,
(
12
)
3497
-
3508
.
Kumar E, Pickard L, Okosun J
(
2021
)
.
Pathogenesis of follicular lymphoma: genetics to the microenvironment to clinical translation
.
British Journal of Haematology
vol.
194
,
(
5
)
810
-
821
.
Heward J, Konali L, D'Avola A, Close K, Yeomans A, Philpott M, Dunford J, Rahim T et al.
(
2021
)
.
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas
.
Blood
vol.
138
,
(
5
)
370
-
381
.
Poynton E, Okosun J
(
2021
)
.
Liquid biopsy in lymphoma: Is it primed for clinical translation?
.
EJHaem
vol.
2
,
(
3
)
616
-
627
.
Larrea E, Fernandez‐mercado M, Guerra‐assunção JA, Wang J, Goicoechea I, Gaafar A, Ceberio I, Lobo C et al.
(
2020
)
.
Identification of recurrent mutations in the microrna‐binding sites of b‐cell lymphoma‐ associated genes in follicular lymphoma
.
International Journal of Molecular Sciences
vol.
21
,
(
22
)
1
-
12
.
Pickard L, Palladino G, Okosun J
(
2020
)
.
Follicular lymphoma genomics
.
Leukemia and Lymphoma
vol.
61
,
(
10
)
2313
-
2323
.
Okosun J, Montoto S
(
2020
)
.
Cellular Therapy in Follicular Lymphoma: Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, and Chimeric Antigen Receptor T-cell Therapy
.
Hematology/Oncology Clinics of North America
vol.
34
,
(
4
)
701
-
714
.
Kumar EA, Okosun J, Fitzgibbon J
(
2020
)
.
The Biological Basis of Histologic Transformation
.
Hematology/Oncology Clinics of North America
vol.
34
,
(
4
)
771
-
784
.
Araf S, Korfi K, Bewicke-Copley F, Wang J, Cogliatti S, Kumar E, Forrer F, Barrington SF et al.
(
2020
)
.
Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma
.
Haematologica
vol.
105
,
(
6
)
E318
-
E321
.
Aries JA, Davies JK, Auer RL, Hallam SL, Montoto S, Smith M, Sevillano B, Foggo V et al.
(
2020
)
.
Clinical Outcome of Coronavirus Disease 2019 in Haemato-oncology Patients
.
British Journal of Haematology
Krysov S, Odabashian M, Carlotti E, Araf S, Okosun J, Spada F, Gribben J, Forconi F et al.
(
2020
)
.
IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution
.
Blood
vol.
135
,
(
11
)
834
-
844
.
Matasar MJ, Luminari S, Barr PM, Barta SK, Danilov AV, Hill BT, Phillips TJ, Jerkeman M et al.
(
2019
)
.
Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs
.
Oncologist
vol.
24
,
(
11
)
e1236
-
e1250
.
Ortega-Molina A, Deleyto-Seldas N, Carreras J, Sanz A, Lebrero-Fernández C, Menéndez C, Vandenberg A, Fernández-Ruiz B et al.
(
2019
)
.
Oncogenic Rag GTPase signalling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR
.
Nature Metabolism
vol.
1
,
(
8
)
775
-
789
.
Araf S, Wang J, Korfi K, Pangault C, Kotsiou E, Rio-Machin A, Rahim T, Heward J et al.
(
2019
)
.
Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma (Leukemia, (2018), 32, 5, (1261-1265), 10.1038/s41375-018-0043-y)
.
Leukemia
vol.
33
,
(
6
)
Kumar E, Okosun J
(
2019
)
.
Follicular lymphoma genomics
.
HemaSphere
vol.
3
,
(
S2
)
79
-
81
.
Araf S, Wang J, Ashton-Key M, Korfi K, Di Bella D, Rio-Machin A, Odabashian M, Foria V et al.
(
2019
)
.
Transmission of diffuse large B-cell lymphoma by an allogeneic stem-cell transplant
.
Haematologica
vol.
104
,
(
4
)
e174
-
e177
.
Okosun J, Kridel R, Fitzgibbon J
(
2018
)
.
Rituximab as a first step in tackling transformation
.
The Lancet Haematology
vol.
5
,
(
8
)
e326
-
e327
.
Heward JA, Kumar EA, Korfi K, Okosun J, Fitzgibbon J
(
2018
)
.
Precision medicine and lymphoma
.
Curr Opin Hematol
vol.
25
,
(
4
)
329
-
334
.
Araf S, Wang J, Korfi K, Pangault C, Kotsiou E, Rio-Machin A, Rahim T, Heward J et al.
(
2018
)
.
Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma
.
Leukemia
vol.
32
,
(
5
)
1258
-
1263
.
Araf S, Okosun J, Fitzgibbon J
(
2018
)
.
Predicting early relapse in follicular lymphoma: have we turned a corner?
.
The Lancet Oncology
vol.
19
,
(
4
)
441
-
442
.
Horton SJ, Giotopoulos G, Yun H, Vohra S, Sheppard O, Bashford-Rogers R, Rashid M, Clipson A et al.
(
2017
)
.
Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors
.
Nature Cell Biology
.
vol.
19
,
1093
-
1104
.
Larrea E, Fernandez-Mercado M, Ceberio I, Assuncao JAG, Okosun J, Fitzgibbon J, Lawrie C
(
2017
)
.
RECURRENT MUTATIONS IN MICRO-RNA BINDING SITES MAY BE POTENTIALLY RELEVANT IN FOLLICULAR LYMPHOMA
.
HAEMATOLOGICA
.
vol.
102
,
94
-
95
.
Mansouri L, Noerenberg D, Young E, Mylonas E, Abdulla M, Frick M, Asmar F, Ljungström V et al.
(
2016
)
.
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma
.
Blood
vol.
128
,
(
23
)
2666
-
2670
.
Araf S, Wang J, Pangault C, Kotsiou E, Hoxha E, Iqbal S, Davies J, Johnson P et al.
(
2016
)
.
GENOMIC PROFILING REVEALS SPATIAL HETEROGENEITY IN FOLLICULAR LYMPHOMA: IMPLICATIONS FOR PRECISION MEDICINE
.
HAEMATOLOGICA
.
vol.
101
,
270
-
270
.
Okosun J, Montoto S, Fitzgibbon J
(
2016
)
.
The routes for transformation of follicular lymphoma
.
Current Opinion in Hematology
vol.
23
,
(
4
)
1
-
1
.
Kotsiou E, Okosun J, Besley C, Iqbal S, Matthews J, Fitzgibbon J, Gribben J, DAVIES JK
(
2016
)
.
TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses
.
Blood
vol.
128
,
(
1
)
72
-
81
.
Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Al Seraihi AF et al.
(
2016
)
.
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
.
Nature Genetics
vol.
48
,
(
2
)
183
-
188
.
Araf S, Okosun J, Koniali L, Fitzgibbon J, Heward J
(
2016
)
.
Epigenetic dysregulation in follicular lymphoma
.
Epigenomics
vol.
8
,
(
1
)
77
-
84
.
Okosun J, Fitzgibbon J
(
2016
)
.
Follicular lymphoma
.
Malignant Lymphomas: Biology and Molecular Pathogenesis
,
Okosun J, Cwynarski K
(
2015
)
.
Non-Hodgkin Lymphoma: High Grade
.
Postgraduate Haematology: Seventh Edition
,
Tawana K, Wang J, Renneville A, Bödör C, Hills R, Loveday C, Savic A, Van Delft FW et al.
(
2015
)
.
Disease evolution and outcomes in familial AML with germline CEBPA mutations
.
Blood
vol.
126
,
(
10
)
1214
-
1223
.
Okosun J, Packham G, Fitzgibbon J
(
2014
)
.
Investigational epigenetically targeted drugs in early phase trials for the treatment of haematological malignancies
.
Expert Opinion on Investigational Drugs
vol.
23
,
(
10
)
1321
-
1332
.
Okosun J, Bödör C, Wang J, Araf S, Yang CY, Pan C, Boller S, Cittaro D et al.
(
2014
)
.
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma
.
Nature Genetics
vol.
46
,
(
2
)
176
-
181
.
Popov N, Maniati E, Marzec J, Okosun J, Scott R, Kranz A, Stewart F, Chelala C et al.
(
2013
)
.
Investigating The Role Of MLL2 (Mll4) In B Cell Development
.
Blood
.
vol.
122
,
343
-
343
.
Okosun J, Clear A, Iqbal S, Matthews J, Gribben J, Fitzgibbon J, Davies J
(
2013
)
.
TNFRSF14 aberrations are associated with death from acute GvHD after reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation for follicular lymphoma
.
BONE MARROW TRANSPLANTATION
.
vol.
48
,
S169
-
S169
.
Bödör C, Grossmann V, Popov N, Okosun J, O’Riain C, Tan K, Marzec J, Araf S et al.
(
2013
)
.
EZH2 mutations are frequent and represent an early event in follicular lymphoma
.
Blood
vol.
122
,
(
18
)
3165
-
3168
.
Montoto S, Shaw K, Okosun J, Gandhi S, Fields P, Wilson A, Shanyinde M, Cwynarski K et al.
(
2012
)
.
HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era
.
Journal of Clinical Oncology
vol.
30
,
(
33
)
4111
-
4116
.
Okosun J, Warbey V, Shaw K, Montoto S, Fields P, Marcus R, Virchis A, McNamara C et al.
(
2012
)
.
Interim fluoro-2-deoxy-D-glucose-PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection
.
AIDS
vol.
26
,
(
7
)
861
-
865
.
Orkin C, Montoto S, Shaw K, Okosun J, Gandhi S, Fields P, Wilson A, Shanyinde M et al.
(
2012
)
.
HIV Status does not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era
.
HIV MEDICINE
vol.
13
,
5
-
5
.
Okosun J, Bödör C, Smith M
(
2011
)
.
Myelodysplastic syndrome: 2011 and beyond
.
British Journal of Nursing
vol.
20
,
(
22
)
Montoto S, Shaw K, Okosun J, Gandhi S, Fields P, Wilson A, Shanyinde M, Cwynarski K et al.
(
2011
)
.
HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era
.
BLOOD
.
vol.
118
,
1557
-
1557
.
Okosun J, Fitzgibbon J
(
2011
)
.
It's a targeted world in non-Hodgkin's lymphoma
.
Br J Nurs
vol.
20
,
(
17
)
Okosun J, Fitzgibbon J
(
2011
)
.
It's a targeted world in non-Hodgkin's lymphoma
.
British Journal of Nursing
vol.
20
,
(
17 SUPPL.
)
Okosun J, Mwirigi A, Kyriakou C, Cwynarski K, Hughes D, Fields P, Mcnamara C
(
2011
)
.
PROGNOSTIC SIGNIFICANCE OF RESPONSE QUALITY (RQ) IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (FL) PATIENTS TREATED WITH COMBINATION RITUXIMAB, CYCLOPHOSPHAMIDE, VINCRISTINE AND PREDNISOLONE (R-CVP)
.
ANNALS OF ONCOLOGY
.
vol.
22
,
218
-
218
.
Okosun J, McNamara C
(
2011
)
.
Paraneoplastic peripheral blood eosinophilia in relapsed follicular lymphoma
.
Leukemia and Lymphoma
vol.
52
,
(
2
)
328
-
330
.
Bower M, Montoto S, Cwynarski K, Lumsden AS, Rajab R, Okosun J, Orkin C, Nelson M et al.
(
2010
)
.
Non-germinal centre subtype of AIDS-related diffuse large B-cell lymphomas associated with improved survival
.
HIV MEDICINE
vol.
11
,
13
-
13
.